Perspective Therapeutics (CATX) Assets Average (2011 - 2026)

Perspective Therapeutics has disclosed Assets Average across 15 years of filings, most recently posting $401.4 million for Q2 2026.

• In Q2 2026, Assets Average rose 25.42% year-over-year to $401.4 million; the TTM figure through Jun 2026 stood at $401.4 million (up 25.42% YoY), while the FY2025 annual figure was $304.0 million, up 38.52% from the prior year.
• Assets Average came in at $401.4 million for Q2 2026 at Perspective Therapeutics, up from $338.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $401.4 million in Q2 2026 to a low of $60.3 million in Q4 2022.
• Average Assets Average over 5 years is $219.2 million, with a median of $234.5 million recorded in 2024.
• Year-over-year, Assets Average jumped 251.35% in 2024 and dropped 23.28% in 2025.
• Over 5 years, Assets Average stood at $60.3 million in 2022, then soared by 72.77% to $104.2 million in 2023, then jumped by 251.35% to $366.1 million in 2024, then fell by 23.28% to $280.9 million in 2025, then surged by 42.9% to $401.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $401.4 million in Q2 2026, $338.9 million in Q1 2026, and $280.9 million in Q4 2025.